Search citation statements
Paper Sections
Citation Types
Publication Types
Relationship
Authors
Journals
for teaching me electrochemistry, and Prof. M. Todd Washington for lending his quench-flow instrument and making me feel welcome in his lab space. The Department of Chemistry has been my home for the past six years, and I will miss everyone in it very much. Last but certainly not least, my thanks go out to everyone in Kansas (my American family) and my amazing mother, Elena Mishanina (my Tajikistan family). Without Pat Radford, Lanora Turner and Dr. Bill Gardner I would not be where I am today. In 2004, my mother watched her 16-year-old daughter leave for a foreign country literally halfway around the world away. We have been apart ever since. It is difficult for me, but I cannot even imagine how hard it is for her. I want to thank her for her sacrifices, support and faith in my abilities and judgment. vi ABSTRACT Antibiotic resistance represents a real threat in the modern world. The problem of resistance is brought about by the fast evolution of bacteria, accelerated by misuse and over-prescription of antibiotics and compounded by the decline in the discovery and development of new classes of antibiotics. Consequently, new targets for antibiotics are in high demand. Flavin-dependent thymidylate synthase (FDTS), which is not present in humans and is responsible for the biosynthesis of a DNA building block in several human pathogens (e.g., M. tuberculosis, B. anthracis, H. pylori), is one such novel target. FDTS catalyzes the reductive methylation of 2′-deoxyuridine-5′-monophosphate (dUMP) to produce 2′-deoxythymidine-5′-monophosphate (dTMP), with N 5 ,N 10-methylene-5,6,7,8tetrahydrofolate (CH 2 H 4 fol) serving as the carbon source and a nicotinamide cofactor as the electron source. No efficient inhibitors of FDTS are known, despite high-throughput screening attempts to find them. Intermediate and transition-state mimics are likely to bind the enzyme with greater affinity and hence have a better chance at inhibiting FDTS. Therefore, the understanding of the chemical mechanism of FDTS is critical to the informed design of compounds capable of disrupting its function in bacteria. We utilized various techniques, including chemical trapping of reaction intermediates, substrate isotope exchange and stopped-flow, to investigate the FDTS mechanism and determine what sets it apart from other pyrimidine methylases. We found that at least two different intermediates kinetically accumulate in the FDTS-catalyzed reaction. Both of these intermediates are trapped in acid in the form of 5-hydroxymethyl-dUMP, which has never been isolated in other uracil-methylating enzymes. Under basic conditions, however, the earlier intermediate is converted to a species with an unusual flavin-derived adduct, while the later intermediate is converted to dTMP product. Our experiments also suggest that dUMP is activated for the reaction by the reduced flavina substrate vii activation mechanism distinct from the one employed by the classical pyrimidinemethylating enzymes. viii TABLE OF CONTENTS LIST OF FIGURES .
for teaching me electrochemistry, and Prof. M. Todd Washington for lending his quench-flow instrument and making me feel welcome in his lab space. The Department of Chemistry has been my home for the past six years, and I will miss everyone in it very much. Last but certainly not least, my thanks go out to everyone in Kansas (my American family) and my amazing mother, Elena Mishanina (my Tajikistan family). Without Pat Radford, Lanora Turner and Dr. Bill Gardner I would not be where I am today. In 2004, my mother watched her 16-year-old daughter leave for a foreign country literally halfway around the world away. We have been apart ever since. It is difficult for me, but I cannot even imagine how hard it is for her. I want to thank her for her sacrifices, support and faith in my abilities and judgment. vi ABSTRACT Antibiotic resistance represents a real threat in the modern world. The problem of resistance is brought about by the fast evolution of bacteria, accelerated by misuse and over-prescription of antibiotics and compounded by the decline in the discovery and development of new classes of antibiotics. Consequently, new targets for antibiotics are in high demand. Flavin-dependent thymidylate synthase (FDTS), which is not present in humans and is responsible for the biosynthesis of a DNA building block in several human pathogens (e.g., M. tuberculosis, B. anthracis, H. pylori), is one such novel target. FDTS catalyzes the reductive methylation of 2′-deoxyuridine-5′-monophosphate (dUMP) to produce 2′-deoxythymidine-5′-monophosphate (dTMP), with N 5 ,N 10-methylene-5,6,7,8tetrahydrofolate (CH 2 H 4 fol) serving as the carbon source and a nicotinamide cofactor as the electron source. No efficient inhibitors of FDTS are known, despite high-throughput screening attempts to find them. Intermediate and transition-state mimics are likely to bind the enzyme with greater affinity and hence have a better chance at inhibiting FDTS. Therefore, the understanding of the chemical mechanism of FDTS is critical to the informed design of compounds capable of disrupting its function in bacteria. We utilized various techniques, including chemical trapping of reaction intermediates, substrate isotope exchange and stopped-flow, to investigate the FDTS mechanism and determine what sets it apart from other pyrimidine methylases. We found that at least two different intermediates kinetically accumulate in the FDTS-catalyzed reaction. Both of these intermediates are trapped in acid in the form of 5-hydroxymethyl-dUMP, which has never been isolated in other uracil-methylating enzymes. Under basic conditions, however, the earlier intermediate is converted to a species with an unusual flavin-derived adduct, while the later intermediate is converted to dTMP product. Our experiments also suggest that dUMP is activated for the reaction by the reduced flavina substrate vii activation mechanism distinct from the one employed by the classical pyrimidinemethylating enzymes. viii TABLE OF CONTENTS LIST OF FIGURES .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.